O	O	0	9	Bacterial	Bacterial	B-NP	JJ	O	2	NMOD	O
O	O	10	28	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	3	SUB	O
O	O	29	38	activates	activate	B-VP	VBZ	O	0	ROOT	O
T9	B-Entity	39	46	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD	B-protein
T9	I-Entity	47	53	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
T9	I-Entity	53	54	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T9	I-Entity	54	60	kappaB	kappaB	I-NP	NN	I-protein	3	OBJ	I-protein
O	O	61	68	through	through	B-PP	IN	O	3	VMOD	O
O	O	69	80	interleukin	interleukin	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	80	81	-	-	B-NP	HYPH	I-protein	13	P	I-protein
O	O	81	82	1	1	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	83	92	signaling	signaling	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	93	102	mediators	mediator	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	103	105	in	in	B-PP	IN	O	3	VMOD	O
O	O	106	114	cultured	culture	B-NP	VBN	B-cell_line	19	NMOD	B-cell_line
O	O	115	120	human	human	I-NP	JJ	I-cell_line	19	NMOD	I-cell_line
O	O	121	127	dermal	dermal	I-NP	JJ	I-cell_line	19	NMOD	I-cell_line
O	O	128	139	endothelial	endothelial	I-NP	JJ	I-cell_line	19	NMOD	I-cell_line
O	O	140	145	cells	cell	I-NP	NNS	I-cell_line	22	NMOD	I-cell_line
O	O	146	149	and	and	O	CC	O	22	NMOD	O
O	O	150	161	mononuclear	mononuclear	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	162	172	phagocytes	phagocyte	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	172	173	.	.	O	.	O	3	P	O

O	O	175	184	Bacterial	Bacterial	B-NP	JJ	O	2	NMOD	O
O	O	185	203	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	9	NMOD	O
O	O	204	205	(	(	O	(	O	5	DEP	O
O	O	205	208	LPS	LPS	B-NP	NN	O	5	DEP	O
O	O	208	209	)	)	O	)	O	2	NMOD	O
O	O	209	210	-	-	O	HYPH	O	2	P	O
O	O	210	218	mediated	mediate	B-NP	VBN	O	9	NMOD	O
O	O	219	225	immune	immune	I-NP	JJ	O	9	NMOD	O
O	O	226	235	responses	response	I-NP	NNS	O	22	SUB	O
O	O	235	236	,	,	O	,	O	9	P	O
O	O	237	246	including	include	B-PP	VBG	O	9	NMOD	O
O	O	247	257	activation	activation	B-NP	NN	O	11	PMOD	O
O	O	258	260	of	of	B-PP	IN	O	12	NMOD	O
O	O	261	270	monocytes	monocyte	B-NP	NNS	B-cell_type	20	NMOD	B-cell_type
O	O	270	271	,	,	O	,	O	20	P	O
O	O	272	283	macrophages	macrophage	B-NP	NNS	B-cell_type	20	NMOD	B-cell_type
O	O	283	284	,	,	O	,	O	20	P	O
O	O	285	288	and	and	O	CC	O	20	NMOD	O
O	O	289	300	endothelial	endothelial	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	301	306	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	306	307	,	,	O	,	O	9	P	O
O	O	308	312	play	play	B-VP	VBP	O	0	ROOT	O
O	O	313	315	an	an	B-NP	DT	O	25	NMOD	O
O	O	316	325	important	important	I-NP	JJ	O	25	NMOD	O
O	O	326	330	role	role	I-NP	NN	O	22	OBJ	O
O	O	331	333	in	in	B-PP	IN	O	22	VMOD	O
O	O	334	337	the	the	B-NP	DT	O	28	NMOD	O
O	O	338	350	pathogenesis	pathogenesis	I-NP	NN	O	37	NMOD	O
O	O	351	353	of	of	B-PP	IN	O	28	NMOD	O
O	O	354	358	Gram	Gram	B-NP	NN	O	33	NMOD	O
O	O	358	359	-	-	O	HYPH	O	33	P	O
O	O	359	367	negative	negative	B-NP	JJ	O	33	NMOD	O
O	O	368	376	bacteria	bacteria	I-NP	NNS	O	29	PMOD	O
O	O	376	377	-	-	B-NP	HYPH	O	37	NMOD	O
O	O	377	384	induced	induce	I-NP	VBN	O	37	NMOD	O
O	O	385	391	sepsis	sepsis	I-NP	NN	O	37	NMOD	O
O	O	392	400	syndrome	syndrome	I-NP	NN	O	26	PMOD	O
O	O	400	401	.	.	O	.	O	22	P	O

O	O	402	412	Activation	Activation	B-NP	NN	O	6	SUB	O
O	O	413	415	of	of	B-PP	IN	O	1	NMOD	O
T10	B-Entity	416	418	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T10	I-Entity	418	419	-	-	O	HYPH	I-protein	5	NMOD	I-protein
T10	I-Entity	419	425	kappaB	kappaB	B-NP	NN	I-protein	2	PMOD	I-protein
O	O	426	428	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	429	436	thought	think	I-VP	VBN	O	6	VC	O
O	O	437	439	to	to	I-VP	TO	O	9	VMOD	O
O	O	440	442	be	be	I-VP	VB	O	7	VMOD	O
O	O	443	451	required	require	I-VP	VBN	O	9	VC	O
O	O	452	455	for	for	B-PP	IN	O	10	VMOD	O
O	O	456	464	cytokine	cytokine	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	465	472	release	release	I-NP	NN	O	11	PMOD	O
O	O	473	477	from	from	B-PP	IN	O	13	NMOD	O
O	O	478	481	LPS	LPS	B-NP	NN	O	18	NMOD	O
O	O	481	482	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	482	492	responsive	responsive	I-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	493	498	cells	cell	I-NP	NNS	I-cell_type	22	NMOD	I-cell_type
O	O	498	499	,	,	O	,	O	22	P	O
O	O	500	501	a	a	B-NP	DT	O	22	NMOD	O
O	O	502	510	critical	critical	I-NP	JJ	O	22	NMOD	O
O	O	511	515	step	step	I-NP	NN	O	14	PMOD	O
O	O	516	519	for	for	B-PP	IN	O	22	NMOD	O
O	O	520	529	endotoxic	endotoxic	B-NP	JJ	O	25	NMOD	O
O	O	530	537	effects	effect	I-NP	NNS	O	23	PMOD	O
O	O	537	538	.	.	O	.	O	6	P	O

O	O	539	543	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	544	546	we	we	B-NP	PRP	O	3	SUB	O
O	O	547	559	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	560	563	the	the	B-NP	DT	O	7	NMOD	O
O	O	564	568	role	role	I-NP	NN	O	7	NMOD	O
O	O	569	572	and	and	I-NP	CC	O	7	NMOD	O
O	O	573	584	involvement	involvement	I-NP	NN	O	3	OBJ	O
O	O	585	587	of	of	B-PP	IN	O	7	NMOD	O
O	O	588	599	interleukin	interleukin	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	599	600	-	-	B-NP	HYPH	O	9	P	O
O	O	600	601	1	1	I-NP	CD	O	9	NMOD	O
O	O	602	603	(	(	O	(	O	16	DEP	O
O	O	603	605	IL	IL	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	605	606	-	-	B-NP	HYPH	I-protein	16	DEP	I-protein
O	O	606	607	1	1	I-NP	CD	I-protein	14	NMOD	I-protein
O	O	607	608	)	)	O	)	O	9	NMOD	O
O	O	609	612	and	and	O	CC	O	20	NMOD	O
O	O	613	618	tumor	tumor	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	619	627	necrosis	necrosis	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	628	634	factor	factor	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	635	636	(	(	O	(	O	28	NMOD	O
T1	B-Protein	636	639	TNF	TNF	B-NP	NN	B-protein	28	NMOD	B-protein
T1	I-Protein	639	640	-	-	O	HYPH	O	24	P	O
T1	I-Protein	640	645	alpha	alpha	O	SYM	O	25	DEP	O
O	O	645	646	)	)	O	)	O	28	NMOD	O
O	O	647	653	signal	signal	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	654	664	transducer	transducer	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	665	674	molecules	molecule	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	675	677	in	in	B-PP	IN	O	7	NMOD	O
O	O	678	681	LPS	LPS	B-NP	NN	O	31	NMOD	O
O	O	682	691	signaling	signaling	I-NP	NN	O	29	PMOD	O
O	O	692	694	in	in	B-PP	IN	O	31	NMOD	O
O	O	695	700	human	human	B-NP	JJ	B-cell_type	37	NMOD	B-cell_type
O	O	701	707	dermal	dermal	I-NP	JJ	I-cell_type	37	NMOD	I-cell_type
O	O	708	719	microvessel	microvessel	I-NP	NN	I-cell_type	37	NMOD	I-cell_type
O	O	720	731	endothelial	endothelial	I-NP	JJ	I-cell_type	37	NMOD	I-cell_type
O	O	732	737	cells	cell	I-NP	NNS	I-cell_type	46	NMOD	I-cell_type
O	O	738	739	(	(	O	(	O	40	DEP	O
O	O	739	744	HDMEC	HDMEC	B-NP	NNS	B-cell_type	40	DEP	B-cell_type
O	O	744	745	)	)	O	)	O	37	NMOD	O
O	O	746	749	and	and	O	CC	O	46	NMOD	O
O	O	750	753	THP	THP	B-NP	NN	B-cell_line	46	NMOD	B-cell_line
O	O	753	754	-	-	B-NP	HYPH	I-cell_line	46	NMOD	I-cell_line
O	O	754	755	1	1	I-NP	CD	I-cell_line	46	NMOD	I-cell_line
O	O	756	765	monocytic	monocytic	I-NP	JJ	I-cell_line	46	NMOD	I-cell_line
O	O	766	771	cells	cell	I-NP	NNS	I-cell_line	32	PMOD	I-cell_line
O	O	771	772	.	.	O	.	O	3	P	O

O	O	773	776	LPS	LPS	B-NP	NN	O	2	NMOD	O
O	O	777	788	stimulation	stimulation	I-NP	NN	O	10	SUB	O
O	O	789	791	of	of	B-PP	IN	O	2	NMOD	O
O	O	792	797	HDMEC	HDMEC	B-NP	NN	B-cell_type	9	NMOD	B-cell_type
O	O	798	801	and	and	I-NP	CC	O	9	NMOD	O
O	O	802	805	THP	THP	I-NP	NN	B-cell_line	9	NMOD	B-cell_line
O	O	805	806	-	-	B-NP	HYPH	I-cell_line	9	NMOD	I-cell_line
O	O	806	807	1	1	I-NP	CD	I-cell_line	9	NMOD	I-cell_line
O	O	808	813	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	814	823	initiated	initiate	B-VP	VBD	O	0	ROOT	O
O	O	824	826	an	an	B-NP	DT	O	15	NMOD	O
O	O	827	829	IL	IL	I-NP	NN	B-protein	15	NMOD	B-protein
O	O	829	830	-	-	B-NP	HYPH	I-protein	15	P	I-protein
O	O	830	831	1	1	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	832	840	receptor	receptor	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	840	841	-	-	O	HYPH	O	22	P	O
O	O	841	845	like	like	B-NP	JJ	O	22	NMOD	O
T11	B-Entity	846	848	NF	NF	I-NP	NN	B-protein	22	NMOD	B-protein
T11	I-Entity	848	849	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T11	I-Entity	849	855	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	856	865	signaling	signaling	I-NP	NN	O	22	NMOD	O
O	O	866	873	cascade	cascade	I-NP	NN	O	10	OBJ	O
O	O	873	874	.	.	O	.	O	10	P	O

O	O	875	877	In	In	B-PP	IN	O	26	VMOD	O
O	O	878	887	transient	transient	B-NP	JJ	O	4	NMOD	O
O	O	888	902	cotransfection	cotransfection	I-NP	NN	O	4	NMOD	O
O	O	903	914	experiments	experiment	I-NP	NNS	O	1	PMOD	O
O	O	914	915	,	,	O	,	O	26	P	O
O	O	916	924	dominant	dominant	B-NP	JJ	B-protein	8	NMOD	B-protein
O	O	925	933	negative	negative	I-NP	JJ	I-protein	8	NMOD	I-protein
O	O	934	941	mutants	mutant	I-NP	NNS	I-protein	26	SUB	I-protein
O	O	942	944	of	of	B-PP	IN	O	8	NMOD	O
O	O	945	948	the	the	B-NP	DT	O	15	NMOD	O
O	O	949	951	IL	IL	I-NP	NN	B-protein	15	NMOD	B-protein
O	O	951	952	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
O	O	952	953	1	1	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	954	963	signaling	signaling	I-NP	NN	O	15	NMOD	O
O	O	964	971	pathway	pathway	I-NP	NN	O	9	PMOD	O
O	O	971	972	,	,	O	,	O	8	P	O
O	O	973	982	including	include	B-PP	VBG	O	8	NMOD	O
T2	B-Protein	983	988	MyD88	MyD88	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	988	989	,	,	O	,	O	25	P	O
T3	B-Protein	990	994	IRAK	IRAK	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	994	995	,	,	O	,	O	25	P	O
T4	B-Protein	996	1001	IRAK2	IRAK2	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	1001	1002	,	,	O	,	O	25	P	O
O	O	1003	1006	and	and	O	CC	O	25	NMOD	O
T5	B-Protein	1007	1012	TRAF6	TRAF6	B-NP	NN	B-protein	17	PMOD	B-protein
O	O	1013	1022	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	1023	1027	both	both	O	CC	O	41	NMOD	O
O	O	1028	1030	IL	IL	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	1030	1031	-	-	B-NP	HYPH	I-protein	41	NMOD	I-protein
O	O	1031	1032	1	1	I-NP	CD	I-protein	29	NMOD	I-protein
O	O	1032	1033	-	-	I-NP	HYPH	O	29	P	O
O	O	1034	1037	and	and	I-NP	CC	O	41	NMOD	O
O	O	1038	1041	LPS	LPS	I-NP	NN	O	41	NMOD	O
O	O	1041	1042	-	-	O	HYPH	O	33	P	O
O	O	1042	1049	induced	induce	B-NP	VBN	O	41	NMOD	O
T12	B-Entity	1050	1052	NF	NF	I-NP	NN	B-protein	38	NMOD	B-protein
T12	I-Entity	1052	1053	-	-	B-NP	HYPH	I-protein	38	NMOD	I-protein
T12	I-Entity	1053	1059	kappaB	kappaB	I-NP	NN	I-protein	41	NMOD	I-protein
O	O	1059	1060	-	-	B-NP	HYPH	O	41	NMOD	O
O	O	1060	1070	luciferase	luciferase	I-NP	NN	B-protein	41	NMOD	B-protein
O	O	1071	1079	activity	activity	I-NP	NN	O	26	OBJ	O
O	O	1079	1080	.	.	O	.	O	26	P	O

O	O	1081	1084	LPS	LPS	B-NP	NN	O	7	NMOD	O
O	O	1084	1085	-	-	B-PP	HYPH	O	1	P	O
O	O	1085	1092	induced	induce	B-NP	VBN	O	7	NMOD	O
T13,T14	B-Entity,B-Entity	1093	1095	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T13,T14	I-Entity,I-Entity	1095	1096	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T13,T14	I-Entity,I-Entity	1096	1102	kappaB	kappaB	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	1103	1113	activation	activation	I-NP	NN	O	8	SUB	O
O	O	1114	1117	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1118	1121	not	not	I-VP	RB	O	8	VMOD	O
O	O	1122	1131	inhibited	inhibit	I-VP	VBN	O	8	VC	O
O	O	1132	1134	by	by	B-PP	IN	O	10	VMOD	O
O	O	1135	1136	a	a	B-NP	DT	O	15	NMOD	O
O	O	1137	1145	dominant	dominant	I-NP	JJ	B-protein	15	NMOD	B-protein
O	O	1146	1154	negative	negative	I-NP	JJ	I-protein	15	NMOD	I-protein
O	O	1155	1161	mutant	mutant	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	1162	1164	of	of	B-PP	IN	O	15	NMOD	O
T6	B-Protein	1165	1170	TRAF2	TRAF2	B-NP	NN	B-protein	16	PMOD	B-protein
O	O	1171	1175	that	that	B-NP	WDT	O	15	NMOD	O
O	O	1176	1178	is	be	B-VP	VBZ	O	18	SBAR	O
O	O	1179	1187	involved	involve	I-VP	VBN	O	19	VC	O
O	O	1188	1190	in	in	B-PP	IN	O	20	VMOD	O
O	O	1191	1194	TNF	TNF	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	1195	1204	signaling	signaling	I-NP	NN	O	21	PMOD	O
O	O	1204	1205	.	.	O	.	O	8	P	O

O	O	1206	1209	LPS	LPS	B-NP	NN	O	4	NMOD	O
O	O	1209	1210	-	-	B-NP	HYPH	O	1	P	O
O	O	1210	1217	induced	induce	I-NP	VBN	O	4	NMOD	O
O	O	1218	1228	activation	activation	I-NP	NN	O	12	NMOD	O
O	O	1229	1231	of	of	B-PP	IN	O	4	NMOD	O
T14	B-Entity	1232	1234	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T14	I-Entity	1234	1235	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T14	I-Entity	1235	1241	kappaB	kappaB	I-NP	NN	I-protein	5	PMOD	I-protein
T14	I-Entity	1241	1242	-	-	B-NP	HYPH	O	12	NMOD	O
T14	I-Entity	1242	1252	responsive	responsive	I-NP	JJ	B-DNA	12	NMOD	B-DNA
T14	I-Entity	1253	1261	reporter	reporter	I-NP	NN	I-DNA	12	NMOD	I-DNA
T14	I-Entity	1262	1266	gene	gene	I-NP	NN	I-DNA	13	SUB	I-DNA
O	O	1267	1270	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1271	1274	not	not	I-VP	RB	O	13	VMOD	O
O	O	1275	1284	inhibited	inhibit	I-VP	VBN	O	13	VC	O
O	O	1285	1287	by	by	B-PP	IN	O	15	VMOD	O
O	O	1288	1290	IL	IL	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	1290	1291	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
O	O	1291	1292	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	1293	1301	receptor	receptor	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	1302	1312	antagonist	antagonist	I-NP	NN	O	16	PMOD	O
O	O	1312	1313	.	.	O	.	O	13	P	O

T7	B-Protein	1314	1318	TLR2	TLR2	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	1319	1322	and	and	I-NP	CC	O	3	NMOD	O
T8	B-Protein	1323	1327	TLR4	TLR4	I-NP	NN	B-protein	4	SUB	B-protein
O	O	1328	1332	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1333	1342	expressed	express	I-VP	VBN	O	4	VC	O
O	O	1343	1345	on	on	B-PP	IN	O	5	VMOD	O
O	O	1346	1349	the	the	B-NP	DT	O	9	NMOD	O
O	O	1350	1354	cell	cell	I-NP	NN	O	9	NMOD	O
O	O	1355	1362	surface	surface	I-NP	NN	O	6	PMOD	O
O	O	1363	1365	of	of	B-PP	IN	O	9	NMOD	O
O	O	1366	1371	HDMEC	HDMEC	B-NP	NN	B-cell_type	16	NMOD	B-cell_type
O	O	1372	1375	and	and	I-NP	CC	O	16	NMOD	O
O	O	1376	1379	THP	THP	I-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	1379	1380	-	-	B-NP	HYPH	I-cell_line	16	NMOD	I-cell_line
O	O	1380	1381	1	1	I-NP	CD	I-cell_line	16	NMOD	I-cell_line
O	O	1382	1387	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	1387	1388	.	.	O	.	O	4	P	O

O	O	1389	1394	These	These	B-NP	DT	O	2	NMOD	O
O	O	1395	1403	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	1404	1411	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1412	1416	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1417	1418	a	a	B-NP	DT	O	8	NMOD	O
O	O	1419	1425	signal	signal	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	1426	1438	transduction	transduction	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	1439	1447	molecule	molecule	I-NP	NN	I-protein	14	SUB	I-protein
O	O	1448	1450	in	in	B-PP	IN	O	8	NMOD	O
O	O	1451	1454	the	the	B-NP	DT	O	13	NMOD	O
T16	B-Entity	1455	1458	LPS	LPS	I-NP	NN	B-protein	13	NMOD	B-protein
T16	I-Entity	1459	1467	receptor	receptor	I-NP	NN	I-protein	13	NMOD	I-protein
T16	I-Entity	1468	1475	complex	complex	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	1476	1479	may	may	B-VP	MD	O	4	SBAR	O
O	O	1480	1486	belong	belong	I-VP	VB	O	14	VC	O
O	O	1487	1489	to	to	B-PP	TO	O	15	VMOD	O
O	O	1490	1493	the	the	B-NP	DT	O	31	NMOD	O
O	O	1494	1496	IL	IL	I-NP	NN	B-protein	31	NMOD	B-protein
O	O	1496	1497	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
O	O	1497	1498	1	1	I-NP	CD	I-protein	31	NMOD	I-protein
O	O	1499	1507	receptor	receptor	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	1507	1508	/	/	B-NP	SYM	O	31	NMOD	O
O	O	1508	1512	toll	toll	I-NP	NN	B-protein	31	NMOD	B-protein
O	O	1512	1513	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
O	O	1513	1517	like	like	I-NP	JJ	I-protein	31	NMOD	I-protein
O	O	1518	1526	receptor	receptor	B-NP	NN	I-protein	31	NMOD	I-protein
O	O	1527	1528	(	(	O	(	O	29	DEP	O
O	O	1528	1531	TLR	TLR	B-NP	NN	B-protein	29	DEP	B-protein
O	O	1531	1532	)	)	O	)	O	31	NMOD	O
O	O	1533	1538	super	super	B-NP	NN	O	31	NMOD	O
O	O	1539	1545	family	family	I-NP	NN	O	16	PMOD	O
O	O	1545	1546	,	,	O	,	O	38	P	O
O	O	1547	1550	and	and	O	CC	O	38	VMOD	O
O	O	1551	1554	the	the	B-NP	DT	O	37	NMOD	O
O	O	1555	1558	LPS	LPS	I-NP	NN	O	37	NMOD	O
O	O	1559	1568	signaling	signaling	I-NP	NN	O	37	NMOD	O
O	O	1569	1576	cascade	cascade	I-NP	NN	O	38	SUB	O
O	O	1577	1581	uses	use	B-VP	VBZ	O	4	SBAR	O
O	O	1582	1584	an	an	B-NP	DT	O	42	NMOD	O
O	O	1585	1594	analogous	analogous	I-NP	JJ	O	42	NMOD	O
O	O	1595	1604	molecular	molecular	I-NP	JJ	O	42	NMOD	O
O	O	1605	1614	framework	framework	I-NP	NN	O	38	OBJ	O
O	O	1615	1618	for	for	B-PP	IN	O	42	NMOD	O
O	O	1619	1628	signaling	signaling	B-NP	NN	O	43	PMOD	O
O	O	1629	1631	as	as	B-PP	IN	O	38	VMOD	O
O	O	1632	1634	IL	IL	B-NP	NN	B-protein	47	NMOD	B-protein
O	O	1634	1635	-	-	B-NP	HYPH	I-protein	45	PMOD	I-protein
O	O	1635	1636	1	1	I-NP	CD	I-protein	47	NMOD	I-protein
O	O	1637	1639	in	in	B-PP	IN	O	38	VMOD	O
O	O	1640	1651	mononuclear	mononuclear	B-NP	JJ	B-cell_type	51	NMOD	B-cell_type
O	O	1652	1662	phagocytes	phagocyte	I-NP	NNS	I-cell_type	54	NMOD	I-cell_type
O	O	1663	1666	and	and	O	CC	O	54	NMOD	O
O	O	1667	1678	endothelial	endothelial	B-NP	JJ	B-cell_type	54	NMOD	B-cell_type
O	O	1679	1684	cells	cell	I-NP	NNS	I-cell_type	49	PMOD	I-cell_type
O	O	1684	1685	.	.	O	.	O	3	P	O
